COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

About the Lab

Dr. Doherty‚Äôs initial research identified novel therapeutic targets for the airway inflammation and remodeling that occur in chronic asthma pathology.  The Doherty lab has since developed a focus on innate type 2 lung responses that contribute to asthma and allergic airway disease.  We have identified novel mechanisms that regulate group 2 innate lymphoid cells (ILC2s) using animal models and human samples.

Funding for the Doherty lab has been provided by: The National Institute of Allergy and Infectious Disease (NIAID), the American Lung Association (ALA), the American Academy of Allergy, Asthma, and Immunology (AAAAI), and UCSD CTRI.